Who We Are
Korea Drug Development Fund
Korea Drug Development Fund (KDDF) is a national R&D initiative funded by three government ministries. We support drug development across academia and the pharmaceutical industry to advance innovative therapeutic pipelines.
Our Purpose
Driven by a mission to advance Korea’s pharmaceutical innovation, KDDF will invest approximately USD 2.0 billion in 1,234 R&D projects by 2030 to accelerate the translation of innovations from academia and the pharmaceutical industry into clinically and commercially viable drug development programs.
Milestones across two seasons
Property Management
Cumulative assets
Approved Drug by
FDA / EMA · MFDS
Licensing Deals
New licenses · Biodollars
How KDDF BD Creates Global Partnering: Five Strategic Pillars
A curated, deal-ready portfolio of strategically selected KDDF-supported projects, positioned for co-development, licensing, and investment.
Providing structured BD consulting to position KDDF-backed projects for co-development, licensing, and global partnering.
Building practical global BD capabilities through hands-on training and real-world partnering exposure.
Enhancing investment readiness through asset valuation and structured access to global investors via partnering platforms.
Connecting KDDF-backed institutions with global pharma and investors through curated platforms and ongoing partnering opportunities. * Annual events held in Seoul, Korea
